Exhalon made DealBio’s list of 6 infection diagnostics startups to watch in 2026 🙏 Breath-based testing for respiratory infections — non-invasive, fast, no consumables.
Still early days, but proud of the team and the science behind it.
dealbio.vc/collections/infec…
4
We were at Vivatech linkedin.com/feed/update/urn…
1
Exhalon retweeted
CARB-X Awards $1M Seed Funding for Exhalon's Breath-Based Lower Respiratory Tract Infection Test 360dx.com/infectious-disease…
Exhalon retweeted
@CARB_X has awarded @ExhalonLabs US$1M in seed funding to evaluate whether exhaled breath can be used as a non-invasive sample type to aid in the rapid and accurate diagnosis of lower-respiratory tract infections (LRTIs).
🔗 Read here: bit.ly/3Kbc5mi
𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗮𝘀 𝗮 𝗰𝗼𝗿𝗻𝗲𝗿𝘀𝘁𝗼𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 #AMR 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲 — non-invasive, rapid tools are vital to guide therapy and curb unnecessary antibiotic use.
#diagnostic #artificalintelligence #Innovation
linkedin.com/posts/exhalon_g…
@ExhalonLabs was at the 1st Global AntiMicrobial Resistance Innovators Conference
#GAMRIC #AMR #diagnostics #ArtificialIntelligence linkedin.com/posts/exhalon_g…
17
@ExhalonLabs à l'événement l'Art du Care, organisé par l'institut @onepoint le 14 octobre. Notre technologie qui s'appuie sur la spectrométrie de masse et de l'#IA pour un #diagnostic médical des patients, non-invasif et instantané et avec de l'#impact.
linkedin.com/posts/onepoint_…
2
21



